drugset / Trial / NCT01588535

Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media

NCT01588535

Phase 2 Completed 38 enrolled Arbor Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This study is to assess the reliability and validity of the FAECC scale to evaluate pain associated with acute otitis media in children aged 2 months to 5 years.

Timeline

Start
2012-05
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzocaine Small molecule 10 mg/ml Other

Indications